The Tech Tour Healthtech Summit announces the Top 20 innovative European entrepreneurs and the winner of the Salus excellence in Healthtech Award

Promising entrepreneurs seeking funding will present to global corporates and VC’s at the 5th annual Tech Tour & IVC Healthtech Summit in Lausanne, June 23-24.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Geneva/Lausanne, Switzerland and Brussels, Belgium (PRWEB UK) 23 June 2014

Promising entrepreneurs seeking funding will present to global corporates and VC’s at the 5th annual Tech Tour & IVC Healthtech Summit in Lausanne, June 23-24. Endosense, one of the 2008 Summit Alumni, will receive the 2014 Salus Excellence in Healthtech Award for its development and commercialization of the TactiCath ablation catheter, an innovative cardiac ablation device for treatment of patients with cardiac arrhythmias.

Geneva/Lausanne and Brussels, June 23, 2014 – The President of the Healthtech Summit, Angelo de Rosa of Medtronic and the Vice President of the Selection Committee, Antoine Papiernik of Sofinnova Partners, announce today the names of the top 20 European healthtech companies as selected by an expert committee to present at the SwissTech Convention Center in Lausanne, Switzerland on June 24th.

Top 20 Presenting Companies:

  •     Abionic
  •     Advanced
  •     Perfusion Diagnostics
  •     Atlas Genetics
  •     Corasis Medical
  •     Endomagnetics
  •     Eye Tech Care
  •     Gene Predictis
  •     G-Therapeutics
  •     Healvetia
  •     Hepa Wash
  •     Lindacare
  •     Limflow – Mdstart
  •     Medlumics
  •     Mindmaze
  •     Mitricares
  •     Nephera
  •     Neuravi
  •     Neurotronik
  •     Plux
  •     Vivasure Medical

Showcase Technology Companies & Industry Experts:

  •     Mainstay Medical
  •     Nexstim
  •     Quanta Fluid Solutions
  •     Sequana Medical

The nominated companies represent 9 countries in various stages of development ranging from seed to expansion from a variety of Healthtech arenas including: 35% Medical Devices, 15% Lifescience/Genetics, 15% Cardiology, 15% Diagnostics & Monitoring, 10% Nanotechnology, 5% Integrated Solutions, and 5% Ophthalmology.

The 2014 Healthtech Summit will feature the 3rd Salus Excellence in Healthtech Award celebrating the success of companies who have consistently demonstrated excellence in commercialization of a new health technology innovation with potential for global impact in healthcare. Past Award Winners include Occlutech in 2011, and EOS Imaging in 2012.

The award selection committee has chosen Endosense as the Award Winner for 2014.

Dr. Brian Hashemi, Chairman of the Advisory Council of the Summit, and Managing Partner at Salus Partners will present the award to Endosense at the gala dinner of the Summit on June 23rd at the Olympic Museum in Lausanne, Switzerland. “Endosense was nominated by the Selection Committee from among a strong list of Summit Alumni for the phenomenal dedication of the entrepreneurial team, and their investors, in successfully commercializing a new cardiac ablation innovation which will significantly improve treatment of patients with cardiac arrhythmias.”

Endosense, now part of St Jude Medical, is a Geneva based company founded in 2003. Major venture capital firms participated in the funding of the company during its ten year independent history. During the Series B financing period, Endosense presented at the first edition of the Tech Tour MedTech Summit in 2008. The company was acquired in 2013 by St. Jude for USD330M. The former CEO of Endosense, Eric Le Royer will be present at the networking dinner of the Summit on June 23rd to receive the award on behalf of the company.

Eric Le Royer commented: “I am thrilled Endosense to be laureate for the 2014 award. This has been an intense team journey conducted over the last ten years I am proud to be part of as co-founder and former CEO. Concluded by the acquisition of St Jude Medical in 2013, one of the highest exits in the European innovation medtech space, all of us who contributed to this outcome are honoured to be recognized among our industry and peers by the Tech Tour and Salus Partners. We are truly looking forward to the event and accepting our Award.”

A delegation of 140 leading global industry players and representatives from cross-venture capital and global investment firms are attending the event. Estimated investment capabilities of attending investors are estimated to 5 billion+ Euros.

For more information please visit: http://www.healthtechsummit.eu.

Media Contacts:
Patrice McCauley            Tanja Baltus    
Marketing Manager, Tech Tour Europe Unlimited                    
+41 22 544 60 62            +32 2 643 36 94                     
patrice(at)techtour(dot)com        tanja(at)e-unlimited(dot)com                     

About the Tech Tour
The Tech Tour was founded in Geneva in 1998 in response to the growing interest in emerging technology companies in various European regions. The Tech Tour is an independent, not-for-profit organization composed of key contributors to the high technology industry. The organization recognizes that continued prosperity in Europe lies in its ability to transform today's innovative projects into tomorrow's global technology leaders. http://www.techtour.com.

About the International Venture Club
The International Venture Club was founded in 2011 as the collaborative platform of leading venture investors promoting successful international investments. Its objectives are to 1) share better practices, 2) build co-investor trust and relations, 3) foster new funding and investment opportunities through joint actions and PR, 4) grow promising companies with corporate partners and co-investors and 5) keep a smart window and support to emerging innovative companies. http://www.iventureclub.com


Contact

Attachments